Zogenix to Participate in the Wells Fargo 2015 Healthcare Conference

Loading...
Loading...

SAN DIEGO, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. ZGNX, a pharmaceutical company developing therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Wells Fargo 2015 Healthcare Conference in Boston, MA, on September 10, 2015.

Wells Fargo 2015 Healthcare Conference
Date: Thursday, September 10, 2015
Time: 8:35 am Eastern Time / 5:35 am Pacific Time
Location: Boston, MA - Hyatt Regency, Room 2

The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at ir.zogenix.com.

About Zogenix

Zogenix, Inc. ZGNX is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit www.zogenix.com.

CONTACT: Investors: Andrew McDonald Founding Partner, LifeSci Advisors LLC 646-597-6987 | Andrew@lifesciadvisors.com
Market News and Data brought to you by Benzinga APIs
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...